EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months

Utku Uysal, Patrick Landazuri iD, David E Burdette, Sanjay Patra, Angela N Crudele, Dario J Englot iD, Jay R Gavvala, Nitin Tandon, Sandipan Pati, Lesley C Kaye, Steven Ojemann, Daniel Barnett und 38 weitere

Epilepsia · 2026

DOI: 10.1002/epi.70321 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia, 2026. Verfasst von Utku Uysal und 49 weiteren Autor:innen. Beteiligte Einrichtung: The University of Kansas Hospital, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Epilepsy, Generalized, Drug Resistant Epilepsy, Thalamus, Deep Brain Stimulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to evaluate the safety and effectiveness of responsive thalamic stimulation as adjunctive therapy for drug‐resistant idiopathic generalized epilepsy (IGE) with generalized tonic–clonic seizures (GTCSs).

Methods

NAUTILUS is a prospective, multicenter, single‐blind, randomized sham‐controlled pivotal trial. Patients were ≥12 years of age with drug‐resistant IGE and ≥2 GTCSs over a 3‐month baseline. Bilateral depth leads were targeted to the centromedian thalamus. One month later, patients were randomized to Active (responsive stimulation, n = 44) or Sham (no stimulation, n = 43). The effectiveness evaluation period (EEP) began 3 months postimplant through 1 year. After a second GTCS in the EEP, patients transitioned to open‐label active stimulation. The primary safety endpoint was the serious adverse device‐related event (SADE) rate at 84 days postimplant. The primary effectiveness endpoint was time‐to‐second‐GTCS during the EEP. Additional endpoints included median percent change in days with any generalized seizure, GTCS frequency, and responder rate (RR).

Results

Eighty‐seven patients were implanted across 23 US centers. The SADE rate was significantly below the performance goal (6.9%, p < .0001), with no adverse effects on cognition, mood, or sleep. The prespecified primary effectiveness endpoint was not significant. However, a post hoc mixed‐effects model considering all EEP days demonstrated greater GTCS reduction in the originally randomized Active group (61%) compared to patients originally randomized to Sham (49%, p = .030). Eighteen‐month outcomes included 76.8% median GTCS reduction, 62.5% RR, 40% GTCS‐free at that timepoint, and 77.8% median reduction in days with any generalized seizure. More than 90% of patients and 86% of physicians reported improvement on Global Impression of Change scales. Significance NAUTILUS is the first randomized controlled neuromodulation trial in IGE. Responsive thalamic stimulation provided a clinically meaningful and durable reduction in seizures with an acceptable safety profile, offering a much‐needed option for drug‐resistant IGE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, GeneralizedDrug Resistant EpilepsyThalamusDeep Brain StimulationHumansFemaleMaleAdultTreatment OutcomeSingle-Blind MethodAdolescentYoung AdultProspective StudiesMiddle Aged

Stichwörter der Autor:innen

RNS systemdrug‐resistant epilepsyidiopathic generalized epilepsyresponsive neurostimulationthalamic stimulation

Autor:innen und Institutionen

  • The University of Kansas Hospital, Kansas City, Kansas, USA.
  • Corewell Health System, Grand Rapids, Michigan, USA.
  • Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • UT Health Houston McGovern School of Medicine, Houston, Texas, USA.
  • University of Minnesota, Minneapolis, Minnesota, USA.
  • University of Colorado, Aurora, Colorado, USA.

ORCID-Profile: Patrick Landazuri, Dario J Englot, Robert Mark Richardson, Jamie Joseph Van Gompel, Lia D Ernst, Ushtar Amin, Jarod L Roland, Alica M Goldman, Chengyuan Wu, Cornelia Drees, Taneeta Mindy Ganguly, Jerzy Szaflarski, Lise Johnson, Jacob Norman

Zitieren

APA

Uysal, U., Landazuri, P., Burdette, D. E., Patra, S., Crudele, A. N., Englot, D. J., Gavvala, J. R., Tandon, N., Pati, S., Kaye, L. C., Ojemann, S., Barnett, D., Neimat, J., Palade, A. E., Rahimpour, S., Arain, A. A., Richardson, R. M., Cash, S. S., Salanova, V., …, & Nautilus Study Group (2026). Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months. Epilepsia. https://doi.org/10.1002/epi.70321

Vancouver

Uysal U, Landazuri P, Burdette DE, Patra S, Crudele AN, Englot DJ, et al. Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months. Epilepsia. 2026. doi:10.1002/epi.70321

BibTeX
@article{Uysal2026,
  author = {Uysal, Utku and Landazuri, Patrick and Burdette, David E and Patra, Sanjay and Crudele, Angela N and Englot, Dario J and Gavvala, Jay R and Tandon, Nitin and Pati, Sandipan and Kaye, Lesley C and Ojemann, Steven and Barnett, Daniel and Neimat, Joseph and Palade, Adriana E and Rahimpour, Shervin and Arain, Amir A and Richardson, Robert Mark and Cash, Sydney S and Salanova, Vicenta and Urban, Alexandra and Welch, William P and Gonzalez-Martinez, Jorge A and Van Gompel, Jamie Joseph and Starnes, Keith and Spencer, David and Ernst, Lia D and Amin, Ushtar and Rivera-Cruz, Angelica and Dugan, Patricia and Fajardo, Marytery and Lallas, Matt and Jobst, Barbara C and Odom, Nicole and Roland, Jarod L and Willie, Jon T and Sheth, Sameer A and Goldman, Alica M and Skidmore, Christopher T and Wu, Chengyuan and Drees, Cornelia and Parker, Jonathon and Ganguly, Taneeta Mindy and Szaflarski, Jerzy and Ghatan, Saadi and Johnson, Lise and Norman, Jacob and Wingeier, Brett and Seale, Cairn G and Morrell, Martha J and Nautilus Study Group, Nautilus Study Group},
  title = {Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70321}
}
Kostenlos starten →